![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Artemis Biotech Limited Hyderabad In, based in India, is a pharmaceutical company.
One of their significant offerings is Simvastatin, Process II, Antioxidant Butylated Hydroxy Toluene 0.01%, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-416 - Rev 00
This Chemical Type CEP, issued on April 02, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1563 associated with this CEP further emphasizes